The hottest healthcare company isn’t even a healthcare company

Nvidia has quietly become one of the most influential players in healthcare technology by supplying the accelerated computing and AI infrastructure that powers everything from imaging to drug discovery. The company's restraint — focusing on enabling the ecosystem rather than owning it — has helped cement its role as the indispensable backbone of the healthcare industry's AI transformation.

Editor's Pick

Top Story This Year's Hottest Healthcare Company Isn't Even a Healthcare Company Nvidia has quietly become one of the most influential players in healthcare technology by supplying the accelerated computing and AI infrastructure that powers everything from imaging to drug discovery. The company's restraint — focusing on enabling the ecosystem rather than owning it — has helped cement its role as the indispensable backbone of the healthcare industry's AI transformation. Sponsored Tax Strategies Every Physician Should Use in 2026 Presented by Gelt AI-native tax firm Gelt combines top human tax experts with AI to help physicians and healthcare practices use data-driven tax strategies to lower liabilities, improve profitability, and future-proof their finances. Learn more.

Featured News

Coalition of Pharmacy Groups Urges Congress to Enact PBM Reform A coalition of major pharmacy organizations urged Congressional leaders to enact long-stalled PBM reforms to curb anti-competitive practices, lower drug costs and stop accelerating pharmacy closures that are limiting patient access to care. Mass General Brigham Spins Out Generative AI Startup Mass General Brigham spun out a new company offering a generative AI platform that can rapidly interpret both structured and unstructured clinical data. Right now, the tool's primary application is to accelerate and improve the accuracy of patient screening for clinical trials. Sobi Grows Its Gout Drug Prospects With $950M Acquisition of Startup Arthrosi Therapeutics Arthrosi Therapeutics' pozdeutinurad is in Phase 3 testing as a treatment for uncontrolled gout. Sobi says this once-daily capsule complements its own asset, an infused biologic medicine currently under FDA review as a third-line gout treatment. Test Your Healthcare Revenue Cycle Management Knowledge [Sponsored] Take our quiz and learn more about perspectives on AI and RCM in healthcare. Beyond the Search Bar: Unlocking Enhanced Care via Remote Patient Support As healthcare continues to become more decentralized, enabling patients to be successful with their therapies at home isn't just a "nice to have," it's a "must have." The OBBBA Is Creating Uncertainty and Disruption: What Health Plans Need to Know Health plans are being asked to adapt quickly, to reconfigure technology, reimagine operations, and anticipate ripple effects that stretch across claims, member engagement, compliance, and workforce strategy.

Video   How Merck Views AI Asheesh Chhabra, VP & Chief Data Officer of Merck, shares how they are viewing AI.

Sponsored As Healthcare and Biopharma Companies Embrace AI, Insurance Underwriters See Risks and Opportunities Presented by Munich Re Specialty – North America In an interview, Munich Re Specialty Senior Vice President Jim Craig talked about the risk that accompanies innovation and the important role that insurers play. Learn More

Resources

Debunked Episode 21: The Drug Price Debate, AI in Healthcare Companies Face Consolidation But How Much? How many companies will be left standing once consolidation hits the AI in healthcare sector? Which pharma companies are working with the Trump administration to lower costs? View Now

MedCity News • PO Box 901 • New York, NY unsubscribe